Assembly Biosciences to Present at Cowen’s 38th Annual Healthcare Conference
Mar 05, 2018 12:01 pm UTC| Business
INDIANAPOLIS, March 05, 2018 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and...
KnowBe4 Expands Into South Africa by Acquiring Popcorn Trainin
Mar 05, 2018 12:01 pm UTC| Business
Tampa Bay, FL, March 05, 2018 -- KnowBe4, the world’s largest security awareness training and simulated phishing platform, announced the acquisition of Popcorn Training, a security company based in Johannesburg and...
IRADIMED CORPORATION to Present at 30th Annual Roth Conference
Mar 05, 2018 12:01 pm UTC| Business
WINTER SPRINGS, Fla., March 05, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer, will present at the 30th Annual Roth Conference in Laguna Niguel, CA....
Astound Commerce Joins Forces With Fluid to Form the Largest Independent Digital Commerce Agency
Mar 05, 2018 12:01 pm UTC| Business
SAN FRANCISCO, March 05, 2018 -- Astound Commerce, the world’s largest privately-held digital commerce agency, has merged today with Fluid, a leading digital customer experience and software solutions company, to create...
BeiGene to Present at Upcoming Investor Conferences
Mar 05, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, March 05, 2018 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...
Anavex Life Sciences Strengthens Management Team and Board of Directors
Mar 05, 2018 12:01 pm UTC| Business
Company Appoints Stephan Toutain as Senior Vice President of Operations and Claus van der Velden to Board of Directors NEW YORK , March 05, 2018 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL),...
miRagen Therapeutics to Participate in Upcoming Investor Conferences
Mar 05, 2018 12:01 pm UTC| Business
BOULDER, Colo., March 05, 2018 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that members of...